Bristol–Myers Squibb

Biopharmaceutical companies, AbbVie and Bristol-Myers Squibb, have announced the formation of a clinical research collaboration to evaluate a combination therapeutic regimen for the treatment of advanced solid tumours. more

25 Sep 2017 12:45 News

Opdivo, also known as nivolumab, will now be available to NHS patients suffering from lung cancer as the drug’s manufacturer, Bristol-Myers Squibb, offers the National Institute for Health and Care Excellence (NICE) a new cancer drugs fund (CDF) deal more

20 Sep 2017 11:24 News

A clinical collaboration between Bristol-Myers Squibb and Clovis Oncology has been announced, which will evaluate the combination of Opdivo (nivolumab) and Rubraca (rucaparib) in Phase II and III trials for multiple tumour types. more

1 Aug 2017 13:38 News

Abbvie, Sanofi and Novo Nordisk seens as most reputable pharma companies in the UK and industry as a whole ranked third most reputable by general public more

29 Jun 2016 11:47 News

Merck and Pfizer’s medication for renal cell carcinoma (RCC) is the most likely immunotherapy combination to first arrive in market, according to Global Data more

18 May 2016 16:21 News

Bristol-Myers Squibb (BMS) and Merck are set to continue their strong rivalry in the head and neck cancer space, according to GlobalData more

29 Apr 2016 11:48 News

Bristol-Myers Squibb has selected Medidata’s Clinical Cloud to help manage, monitor and analyse its clinical trials data more

26 Apr 2016 14:20 News

University of Leeds researchers are part of the £20.4m Advanced Digital Design of Pharmaceutical Therapeutics (ADDoPT) programme introducing digital design processes to the pharmaceutical industry more

28 Jan 2016 11:33 News

As part of the agreement, BMS and Ono will jointly develop and commercialise Opdivo (nivolumab) and Yervoy (ipilimumab) across a broad range of tumour types. more

24 Jul 2014 12:06

Recipharm has announced that its sixth International Environmental Award has been awarded to Ludwig Metz, Associate Director Environmental, Health & Safety, at pharmaceutical company Bristol–Myers Squibb. more

7 Feb 2014 15:33 Technology